Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQCommunication ServicesAdvertising AgenciesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.79 → 5.79 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ZD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete Connectivity business divestiture | Ziff Davis is completing the divestiture of its Connectivity business, unlocking shareholder value. | Recovered | Divestiture progress stalls or reverses | Divestiture completed 2026-06-17 vs 2026 target Ziff Davis completed the sale of its Connectivity division to Accenture on June 17, 2026, fulfilling the divestiture thesis. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a recovery and execution thesis, not a clearly durable compounder on the evidence available. The multi-year view is intact, but the business still needs to show more consistent operating progress.
ZD is assessed as cheap versus peers, and its valuation rose recently. The pricing data suggests only weak execution is reflected, while the expectations gap is negative; confidence in these valuation signals is low.
Near term, consecutive earnings misses and a high-miss-rate industry make the next report an important risk. Cash from operations and free cash flow improved through 2026-Q2, but operating results were mixed, including a goodwill impairment and lower adjusted EBITDA.
A guidance cut on the next call would weaken the thesis, while improved cash generation and better operating efficiency would support it. The Connectivity divestiture remains a watch item; easier rates and stronger results from sector peers could also help the sector backdrop.
Over the next 1 to 3 years, ZD’s long-term thesis depends on turning better cash generation into more consistent operating execution. The setup is supported by peer-relative cheapness, but earnings risk and a sector headwind remain important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 3 supplied quarters. Management reported: ““We remain focused on unlocking value for our shareholders as we look to complete the divestiture of the Connectivity business as well as explore additional value-creating transactions,” said Vivek Shah, CEO of Ziff Davis.” ““We are focused on deploying capital strategically to maximize long-term shareholder returns.”” Revenue was $286.738 million in 2026-Q2.
EPS near $6.96 in FY25 | EPS guidance is reaffirmed near $6.96 per share for 2025. | Broken | EPS falls below $6.64 in FY25 | Diluted EPS: $17.16 per share FY2026-Q2; GAAP. Published target: ~$6.96. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 202617.16 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operational efficiency | The company targets operational efficiency improvements, supporting stable revenue near $1.47 billion in 2025. | Intact | Operational efficiency deteriorates | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $1.47B in FY25 | A primary condition in Ziff Davis's published investment case. The stated target is ~$1.47B. | Under Pressure | Revenue falls below $1.44B in FY25 | Revenue: $286.738M FY2026-Q2; GAAP. Published target: ~$1.47B. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 2026286,738,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$5.52 → $5.79 · observed estimates
$1.24B → $1.21B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $5.52 | $1,237,571,287 | 2 / 3 |
| 2026-07-25 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-07-26 | $5.69 | $1,235,464,110 | 4 / 4 |
| 2026-07-27 | $5.69 | $1,235,464,110 | 4 / 4 |
| 2026-07-28 | $5.52 | $1,237,571,287 | 2 / 3 |
| 2026-07-29 | $5.52 | $1,237,571,287 | 2 / 3 |
| 2026-07-30 | $5.69 | $1,235,464,110 | 4 / 4 |
| 2026-07-31 | $5.52 | $1,237,571,287 | 2 / 3 |
| 2026-08-01 | $5.52 | $1,237,571,287 | 2 / 3 |
| 2026-08-02 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-03 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-04 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-05 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-06 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-08 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-09 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-10 | $5.63 | $1,235,464,110 | 4 / 4 |
| 2026-08-12 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-13 | $5.76 | $1,202,610,030 | 4 / 4 |
| 2026-08-14 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-15 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-16 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-17 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-18 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-19 | $5.52 | $1,237,639,287 | 2 / 3 |
| 2026-08-20 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-21 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-22 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-23 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-24 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-25 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-26 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-27 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-28 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-29 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-30 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-08-31 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-01 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-02 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-03 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-04 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-05 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-06 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-07 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-08 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-09 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-10 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-11 | $5.76 | $1,202,707,528 | 2 / 3 |
| 2026-09-12 | $5.79 | $1,207,015,389 | 2 / 3 |
| 2026-09-13 | $5.79 | $1,207,015,389 | 2 / 4 |
| 2026-09-14 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-15 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-16 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-17 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-18 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-19 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-20 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-21 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-22 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-23 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-24 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-25 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-26 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-27 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-28 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-29 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-09-30 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-01 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-02 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-03 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-04 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-05 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-06 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-07 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-08 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-09 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-10 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-11 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-12 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-13 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-14 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-15 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-16 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-17 | $5.79 | $1,207,015,389 | 3 / 4 |
| 2026-10-18 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-19 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-20 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-21 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-22 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-23 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-24 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-25 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-26 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-27 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-28 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-29 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-30 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-10-31 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-11-01 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-11-02 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-11-03 | $5.79 | $1,207,013,389 | 3 / 4 |
| 2026-11-04 | $5.79 | $1,207,013,389 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.